Singh Aastha, Singh Abhishek, Sen Dwaipayan
School of Bio Sciences and Technology, VIT University, Vellore, India.
Cellular and Molecular Therapeutics Laboratory, Centre for Biomaterials, Cellular and Molecular Theranostics (CBCMT), VIT University, Vellore, 632014, Tamil Nadu, India.
Stem Cell Res Ther. 2016 Jun 4;7(1):82. doi: 10.1186/s13287-016-0341-0.
Mesenchymal stem cells have been used for cardiovascular regenerative therapy for decades. These cells have been established as one of the potential therapeutic agents, following several tests in animal models and clinical trials. In the process, various sources of mesenchymal stem cells have been identified which help in cardiac regeneration by either revitalizing the cardiac stem cells or revascularizing the arteries and veins of the heart. Although mesenchymal cell therapy has achieved considerable admiration, some challenges still remain that need to be overcome in order to establish it as a successful technique. This in-depth review is an attempt to summarize the major sources of mesenchymal stem cells involved in myocardial regeneration, the significant mechanisms involved in the process with a focus on studies (human and animal) conducted in the last 6 years and the challenges that remain to be addressed.
几十年来,间充质干细胞一直被用于心血管再生治疗。在动物模型和临床试验中经过多次测试后,这些细胞已被确立为潜在的治疗剂之一。在此过程中,已确定了间充质干细胞的各种来源,这些来源通过激活心脏干细胞或使心脏的动脉和静脉血管再生来帮助心脏再生。尽管间充质细胞疗法备受赞誉,但仍存在一些挑战,要将其确立为一项成功的技术,这些挑战仍需克服。本深入综述旨在总结参与心肌再生的间充质干细胞的主要来源、该过程中涉及的重要机制,重点关注过去6年进行的(人类和动物)研究以及有待解决的挑战。